Sjoukje F Oosting

5PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

|Sep 10, 2025
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome.

S Hone Lopez, S Loipfinger, A Bhattacharya

|Nov 17, 2022
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.

Sarah R Verhoeff, Sjoukje F Oosting, Sjoerd G Elias

|Sep 14, 2020
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.

Johannes Stelwagen, Sjoukje Lubberts, Lars C Steggink

|Sep 04, 2019
Serotonin and Dopamine Receptor Expression in Solid Tumours Including Rare Cancers.

Marloes A M Peters, Coby Meijer, Rudolf S N Fehrmann

Pageof 1

Frequent Collaborators

1 joint publications

S Hone Lopez

1 joint publications

S Loipfinger

1 joint publications

A Bhattacharya

1 joint publications

M Jalving